1
Vernon G Wong, Mae W L Hu: Methods for treating inflammation-mediated conditions of the eye. Oculex Pharmaceuticals, Morrison & Foerster, April 27, 2004: US06726918 (114 worldwide citation)

Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous ...


2
Vernon G Wong, Mae W L Hu: Implants and methods for treating inflammation-mediated conditions of the eye. Allergan, Louis V Wollenberger, Joel B German, Debra D Condino, August 14, 2012: US08242099 (9 worldwide citation)

Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous ...


3
Vernon G Wong, Mae W L Hu: Implants and methods for treating inflammation-mediated conditions of the eye. Allergan, Louis V Wollenberger, Joel B German, Debra D Condino, November 22, 2011: US08063031 (8 worldwide citation)

Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous ...


4
Wong Vernon G, Hu Mae W L: Methods for treating inflammation-mediated conditions of the eye. Oculex Pharmaceuticals, Wong Vernon G, Hu Mae W L, sSHORTLE Rebecca, January 10, 2002: WO/2002/002076 (3 worldwide citation)

Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous ...


5
Vernon G Wong, Mae W L Hu: Implants and methods for treating inflammation-mediated conditions of the eye. Allergan, Laura L Wine, Joel B German, Debra D Condino, April 21, 2015: US09012437 (1 worldwide citation)

Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous ...


6
Vernon G Wong: Methods for treating edema in the eye and intraocular implants for use therefor. Allergan, Laura L Wine, March 14, 2017: US09592242

Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.


7
WONG VERNON G , HU MAE W L : [de] VERFAHREN ZUR BEHANDLUNG VON ENTZÜNDUNGSBEDINGTEN ZUSTÄNDEN DER AUGEN, [en] METHODS FOR TREATING INFLAMMATION-MEDIATED CONDITIONS OF THE EYE, [fr] PROCÉDÉS DE TRAITEMENT DES ÉTATS INFLAMMATOIRES DE L OEIL. ALLERGAN  , May 17, 2017: EP3167872-A1

[en] Methods for treating inflammation-mediated conditions of the eye are described comprising implanting into the vitreous of the eye of an individual a bio-erodible implant comprising a steroidal anti-inflammatory agent and a bio-erodible polymer.


8
Wong Vernon G, Hu Mae W L: Procedes servant a traiter des etats inflammatoires de loeil, Methods for treating inflammation-mediated conditions of the eye. Oculex Pharmaceuticals, Allergan, BORDEN LADNER GERVAIS, January 10, 2002: CA2414680

Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous ...


9
Wong Vernon G, Hu Mae W L: Methods for treating inflammation-mediated conditions of the eye. Oculex Pharm, April 2, 2003: EP1296645-A2

Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous ...


10
Wong Vernon G, Hu Mae W L: Methods for treating inflammation of the eye. Allergan, March 22, 2006: EP1637126-A2

Methods for treating inflammation-mediated conditions of the eye are described comprising implanting into the vitreous of the eye of an individual a bio-erodible implant comprising a steroidal anti-inflammatory agent and a bio-erodible polymer.